Tags » Johnson & Johnson

Johnson Johnson's Biosense Webster buys medical device company Coherex Medical

Biosense Webster has acquired Coherex Medical, Inc. a privately held medical device company based in Salt Lake City, Utah.

As said in Johnson Johnson press release on Friday, Coherex Medical is focused on the development of the Coherex WaveCrest  Left Atrial Appendage (LAA) Occlusion System. 243 more words


Health Canada to review Janssen's NDS for daratumumab for Multiple Myeloma

Health Canada has accepted for review Janssen’s new drug submission (NDS) for daratumumab for treatment of Multiple Myeloma.

Janssen announced on Wednesday that Health Canada would review the submission with advance consideration under the Ministry’s Notice of Compliance with Conditions Policy (NOC/c) based on data from the Phase 2 MMY2002 (SIRIUS) monotherapy study. 130 more words


Janssen's Darzalex for multiple myeloma gets nod in US

The U.S. Food and Drug Administration (FDA) has approved Darzalex (daratumumab) injection for intravenous infusion for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double-refractory to a PI and an immunomodulatory agent. 490 more words


Study: Janssen’s OLYSIO safe for treating hepatitis C virus Patients (Egypt)

The OSIRIS trial Phase II a, Janssen-Cilag has conducted investigating once daily OLYSIO (simeprevir) in combination with sofosbuvir in hepatitis C virus (HCV) genotype 4 infected patients, with and without liver cirrhosis, demonstrated treatment to be safe and generally well tolerated, with Sustained Virological Response (SVR12) rates of up to 100% in patients treated for 12 weeks regardless of fibrosis stage and treatment history. 459 more words


Carat Emerges World’s Leading Media Agency

Once again Carat has emerged the world’s leading media agency network, after regaining the top spot from MediaCom.

The Dentsu Aegis network has taken the top spot in Recma’s Qualitative Network Diagnostics report, pushing MediaCom to second place. 220 more words

Business News

Lawsuit launched over adverse reaction to prescriptions

A 14-year-old Saskatoon boy is suing two pharmaceutical companies after allegedly having an adverse reaction to a drug and developing enlarged breasts.

According to a statement of claim filed in the Regina Court of Queen’s Bench on Oct. 230 more words

Local News